Forward Therapeutics, Inc. is a biotechnology company headquartered in Palm Beach Gardens, Florida, United States, advancing a data-driven pipeline of oral small molecule therapies for inflammation-driven diseases.
Subscribe to see Forward Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Forward Therapeutics is a biotechnology company headquartered in Palm Beach Gardens, United States. Its most recent funding round, Series A, raised $50M in November 2023. Xcout tracks 12 named people at Forward Therapeutics, including STUART CHAFFEE (Chief Executive Officer).
As of 16 November 2026. Source: Xcout Intel.
6 more named people on record for Forward Therapeutics, with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $50M | 3 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Forward Therapeutics's closest competitors — see the full list of competitors and alternatives →
Forward Pharma A/S is a clinical-stage biotechnology company driven by research and discovery, with headquarters located in Denmark.
Jupiter Biomedical Research, Inc. is a biomedical research company founded in 2016 and located in Palm Beach Gardens, Florida. The company is focused on developing innovative drug candidates to treat serious diseases.
Flashpoint Therapeutics is a clinical-stage biotechnology research company headquartered in Evanston, Illinois, developing a new class of precision-engineered structural nanomedicines through its proprietary platform.
Avere Therapeutics is a biotechnology company headquartered in Philadelphia, Pennsylvania, focused on developing oral therapies for the treatment of IL-23-driven inflammatory diseases.
Mysthera Therapeutics AG is a biotechnology company headquartered in Basel, Switzerland, focused on developing first-in-class, oral therapeutics to treat inflammation-driven and related diseases.
First Tracks Biotherapeutics, Inc., situated in San Diego, California, specializes in pioneering new immunology-based treatments. The firm is actively involved in the discovery and progression of therapeutics aimed at combating autoimmune and inflammatory disorders, currently advancing programs like rosnilimab, ANB033, and ANB101 through their clinical stages.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Forward Therapeutics? Suggest a correction · Work at Forward Therapeutics? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.